We set to determine its normal expression pattern in the human brain, and its change, if any, with age and Alzheimer’s disease (AD)-type β-amyloid (Aβ) and Tau pathogenesis. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.